Long term follow-up analysis of HD9601 trial comparing ABDV VS Stanford V VS moppabvcad in patients with newly diagnosed advanced stage Hodgkin lymphoma. A study from the Intergruppo Italiano Linfomi (ILL)

Chisesi, T.; Bellei, M.; Luminari, S.; Marcheselli, L.; Levis, A.; Vitolo, U.; Stelinato, C.; Pavone, V.; Merli, F.; Liberati, M.; Baldini, L.; Bordonaro, R.; Pesce, E.; Gobbi, P.; Federico, M.

Long term follow-up analysis of HD9601 trial comparing ABDV VS Stanford V VS moppabvcad in patients with newly diagnosed advanced stage Hodgkin lymphoma. A study from the Intergruppo Italiano Linfomi (ILL) / T. Chisesi, M. Bellei, S. Luminari, L. Marcheselli, A. Levis, U. Vitolo, C. Stelinato, V. Pavone, F. Merli, M. Liberati, L. Baldini, R. Bordonaro, E. Pesce, P. Gobbi, M. Federico. - In: BLOOD. - ISSN 0006-4971. - 112:11(2008), p. 902 (Abs 2602). ((Intervento presentato al 50. convegno ASH Annual Meeting tenutosi a San Francisco nel 2008.